Biomerica, Inc.
Cash Flow Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.5M | $-908.6K | $-1.5M | $-331.4K | $-215.7K | $537.0K | $548.4K | $157.4K |
| Depreciation & Amortization | $111.1K | $144.9K | $156.3K | $178.2K | $177.5K | $187.3K | $147.3K | $130.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $75.5K | $74.3K | $76.1K | $75.1K | $29.5K | $29.4K | $32.8K | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-1.2M | $-722.9K | $-208.8K | $-405.5K | $-862.3K | $1.4M | $147.4K | $328.8K |
| Investing Activities | ||||||||
| Capital Expenditures | $130.3K | $96.1K | $91.6K | $10.5K | $137.2K | $257.1K | $164.8K | $141.1K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-130.3K | $-96.1K | $-95.2K | $-22.8K | $-282.5K | $-257.1K | $-113.2K | $-431.7K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.3M | $157.7K | $1.1M | $9.6K | $185.3K | $258.5K | $55.4K | $37.9K |
| Net Change in Cash | $-20.6K | $-663.5K | $800.6K | $-420.8K | $-960.7K | $1.4M | $88.1K | $-65.9K |
| Free Cash Flow | $-1.3M | $-818.9K | $-300.3K | $-416.0K | $-999.5K | $1.1M | $-17.4K | $187.7K |